GRAIL Company Overview
GRAIL is a healthcare company dedicated to revolutionizing cancer detection. With their cutting-edge multi-cancer early detection (MCED) test, called Galleri, they aim to detect cancer at an early stage when it is most treatable and curable. The test can identify abnormal methylation patterns associated with over 50 cancer types by analyzing DNA fragments in the bloodstream. GRAIL's innovative technology, backed by a team of leading scientists, engineers, and clinicians, is poised to change the trajectory of cancer mortality. Their mission is to bring together stakeholders and adopt safe, effective technologies that transform cancer care.
GRAIL Valuation History
FAQ
Does GRAIL have stock?
Yes, GRAIL and almost all privately held companies issue stock so founders, employees, and investors can participate in equity ownership. However, because GRAIL is privately held, it is more challenging to acquire shares than if the company was publicly traded.
Is GRAIL publicly traded?
Yes, GRAIL is publicly traded. Since this company is no longer private, we encourage investors to refer to its official SEC filings for up-to-date details. The information provided herein is for reference purposes and may be outdated, as we primarily track private companies.
Who owns GRAIL stock?
As a privately held company, GRAIL shares are held by its founders, management, employees, venture capital funds, or other private individuals and institutional investors.
Disclosure rules differ for private and public companies, so it may not always be possible to know the complete ownership (cap table) of a private company like GRAIL.
Can I buy GRAIL stock on UpMarket?
If you would like to buy shares in GRAIL, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss GRAIL stock availability. Note: inquiries are non-binding, subject to market availability, and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, GRAIL as well.
What is GRAIL stock price?
The stock price of GRAIL can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming GRAIL has issued 250 million shares, at the estimated UpMarket valuation of $10.99 billion, each share of GRAIL stock would be worth $43.96.
How do GRAIL pre-IPO trades work?
Pre-IPO trades for GRAIL will typically involve accredited investors purchasing shares from current shareholders through specialized investment platforms like UpMarket. Trades generally occur on the secondary market, meaning GRAIL doesn't issue new shares or receive capital–shares are privately exchanged between two parties.
While investors aim to profit from a potential IPO or acquisition, these investments carry high risks due to limited liquidity and information. Understanding all terms and conditions is crucial, as each transaction can have unique characteristics. Investing in private companies can be extremely risky and may result in significant capital loss.
How do I exit my investment if I invest in GRAIL with UpMarket?
Exiting your investment in GRAIL typically involves one of these scenarios: 1) selling your shares on a secondary market to other interested investors; 2) holding shares until a liquidity event occurs, such as the company going public (IPO) or being acquired.
Investors must know that the timing and availability of these exit options are inherently unpredictable, and there is no guarantee of when or if they will occur.
How can I sell GRAIL shares?
If you own GRAIL shares, you may be able to find a buyer on a pre-IPO marketplace or via an introduction by a registered broker-dealer like UpMarket. It is important to note that the class of shares you own may impact your ability to sell. For example, shares issued to startup employees often have transaction limitations, including lock-up periods and a right of first refusal by the company, which may prevent you from selling your shares freely.
How does UpMarket estimate the valuation of GRAIL?
UpMarket’s valuation estimate for GRAIL is algorithmically generated based on recent primary round financings by GRAIL, market conditions, company popularity, sector performance, and public market comps.
It is important to note that UpMarket’s valuation estimate for GRAIL could be outdated, may not reflect all recent news or market events, and is not intended to inform any investment decision-making. UpMarket’s valuation estimate is not meant to be a warranty or projection of potential financial returns or company performance. Valuations can change rapidly and unexpectedly.
Why choose UpMarket?
UpMarket was founded in 2019 and has helped hundreds of investors access alternative investments. UpMarket is a licensed broker-dealer based in the United States. UpMarket customers have invested over $150 million in pre-IPO companies, hedge funds, private equity, real estate, and other alternatives.
If you are an accredited investor, you can create a free account to access our deal flow and opportunities. There is never any pressure to invest.
UpMarket clients have invested in companies like
GRAIL,
SpaceX, Neuralink, Anthropic, and many others. UpMarket and its leadership have been mentioned in media outlets like Forbes, WealthManagement, Wealth and Finance News, and TechBullion.
GRAIL Management
| Name | Position |
|---|---|
| Bob Ragusa | CEO |
| Joshua Ofman | President |
| Sir Harpal Kumar | President |
